ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1255

Vascular Calcification On Hand and Feet X-Rays, VFA Imaging of the Spine, and Cardiovascular Disease in Rheumatoid Arthritis

Ausaf Mohammad1, Collette English2, Derek Lohan2, Diane Bergin2, Sarah Mooney2, John Newell3, Martin O'Donnell4, Robert J. Coughlan1 and John J. Carey1, 1Rheumatology, Galway University Hospitals, Galway, Ireland, 2Radiology, Galway University Hospitals, Galway, Ireland, 3Clinical Research Facility, National University of Ireland, Galway, Ireland, 4Clinical Research Facility, Galway University Hospitals, Galway, Ireland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, Cardiovascular disease, fractures, osteoporosis and radiography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Vascular Calcification on Hand and Feet X-rays, VFA imaging of the spine, and Cardiovascular Disease in Rheumatoid Arthritis

Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of osteoporosis (OP) and cardiovascular disease (CVD), and have increased cardiovascular mortality compared with the general population. Vascular calcification (VC) is independent predictor of incident CVD and mortality in RA patients. While VC may be present on plain films of the hands and feet, little is known about the significance of this entity in RA patients. We evaluated the prevalence of VC on hands and feet radiographs, the association with VFA-detected abdominal aortic calcification (AAC) and other CVD risk factors, and the prevalence of CVD in RA patients.

Methods: We conducted a cross-sectional study on our RA subjects ≥40 years of age, who met 1987 ACR criteria for RA classification, and had hands and feet radiographs available for analysis. Risk factors and details of CVD were recorded, and DXA and VFA scans were reviewed where available. Study was approved by local I.R.B. Two blinded musculoskeletal radiologists examined all radiographs for the presence of VC as either “present” or “absent”, and VFA scans to detect and quantify the presence of AAC. We compared the prevalence of VC between RA patients with and without CVD using multivariable logistic regression, and determined if VC on hands and feet radiographs was independently associated with VFA-detected AAC and prevalent CVD.

Results: 854 RA patients met the inclusion criteria, 603 of whom also had a VFA scan available for analysis: 69% female mean age 59 years and 77% seropositive (Table 1). 230 subjects had ≥1 documented CVD event. VC was observed on radiographs in 94(11%) and a higher proportion of subjects had prevalent CVD (49% Vs 24%). Of the 603 who had a VFA scan available, 211(35%) of the subjects had AAC. A greater proportion of those with VC on plain films had AAC on VFA (36% Vs 23%). In multivariable analyses, VC presence was significantly and independently associated with AAC (OR 1.80; 95% CI 1.55 to 1.98; p< 0.05) and prevalent CVD (OR 2.30; 95% CI 1.8 to 2.8; p<0.05).

Conclusion:  We found a significant association between VC on hands and feet radiographs and abdominal aortic calcification and CVD in our RA cohort. The presence of VC should alert physicians to the presence of CVD in patients with RA.

 

Table 1: Demographics and Clinical Features of 854 RA Patients According to the Presence of VC on Hand and Feet X-rays

 

Variables

VC positive

(n = 94)

VC negative

(n = 760)

 

p Value

Age (years)

Women – n (%)

Smokers – n (%)

RA duration (years)

Family history of CVD – n (%)

Diabetes – n (%)

Dyslipidemia – n (%)

Prevalent CVD

Hypertension – n (%)

Glucocorticoid use – n (%)

RF positive – n (%)

Anti-CCP positive – n (%)

C-reactive protein (mg/l)

DAS28, mean ± SD

AAC on VFA – n (%)

 

59 ± 12.74

65 (69)

60 (64)

15 ± 9

39 (41)

15 (16)

41 (43)

46 (49)

45 (48)

23 (24)

69 (73)

71 (76)

5.50 ± 3.52

2.98 ± 0.90

34 (36)

 

56 ± 9.67

525 (69)

396 (52)

13 ± 6

200 (26)

112 (15)

260 (34)

184 (24)

167 (22)

120 (16)

590 (78)

540 (71)

3.31 ± 1.86

1.92 ± 0.86

177 (23)

0.012

0.890

0.003

0.006

0.003

0.540

0.003

<0.001

<0.001

0.017

0.021

0.013

<0.001

<0.001

0.034

 



Disclosure:

A. Mohammad,
None;

C. English,
None;

D. Lohan,
None;

D. Bergin,
None;

S. Mooney,
None;

J. Newell,
None;

M. O’Donnell,
None;

R. J. Coughlan,
None;

J. J. Carey,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascular-calcification-on-hand-and-feet-x-rays-vfa-imaging-of-the-spine-and-cardiovascular-disease-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology